# Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances Page: https://stenobird.com/podcast/lung-cancer-update-827388/non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances Text version: https://stenobird.com/podcast/lung-cancer-update-827388/non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md Podcast: [Lung Cancer Update](https://stenobird.com/podcast/lung-cancer-update-827388) Published: 2025-08-08T15:00:00+00:00 Episode link: https://lung-cancer-update.captivate.fm/episode/5521-yir2024-nontargetedlung Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/d755cd82-e980-4e79-aca5-1b58ef497e43.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances Duration seconds: 3542 ## Resource Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.  CME information and select publications here . ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/lung-cancer-update-827388/non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.